| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Elekta AB (publ) (ST: EKTA-B)
EKTA-B Technical Analysis
1.5
| As on 9th Jun 2023 EKTA-B SHARE Price closed @ 83.82 and we RECOMMEND Buy for LONG-TERM with Stoploss of 74.09 & Sell for SHORT-TERM with Stoploss of 95.32 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EKTA-BSHARE Price
| Open | 84.70 | Change | Price | % |
| High | 84.92 | 1 Day | 0.34 | 0.41 |
| Low | 83.26 | 1 Week | -0.28 | -0.33 |
| Close | 83.82 | 1 Month | -2.36 | -2.74 |
| Volume | 909703 | 1 Year | -28.28 | -25.23 |
| 52 Week High 116.35 | 52 Week Low 54.32 | ||||
ST Sweden Most Active Stocks
| QUIA | 0.02 | 0.00% |
| QLIFE | 0.04 | 0.00% |
| SBB-B | 5.38 | 3.07% |
| STRLNG | 0.12 | 33.33% |
| LUNE | 21.97 | 6.65% |
| SAS | 0.36 | 5.88% |
| URBIT | 0.02 | 0.00% |
| IDOGEN | 0.15 | -31.82% |
| STAR-B | 0.89 | -1.11% |
| TELIA | 24.60 | 0.41% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| EKTA-B Daily Charts |
EKTA-B Intraday Charts |
Whats New @ Bazaartrend |
EKTA-B Free Analysis |
|
|
EKTA-B Important Levels Intraday
| RESISTANCE | 87.02 |
| RESISTANCE | 85.99 |
| RESISTANCE | 85.36 |
| RESISTANCE | 84.72 |
| SUPPORT | 82.92 |
| SUPPORT | 82.28 |
| SUPPORT | 81.65 |
| SUPPORT | 80.62 |
EKTA-B Forecast April 2024
| 4th UP Forecast | 141.09 |
| 3rd UP Forecast | 122.72 |
| 2nd UP Forecast | 111.37 |
| 1st UP Forecast | 100.02 |
| 1st DOWN Forecast | 67.62 |
| 2nd DOWN Forecast | 56.27 |
| 3rd DOWN Forecast | 44.92 |
| 4th DOWN Forecast | 26.55 |
EKTA-B Weekly Forecast
| 4th UP Forecast | 98.56 |
| 3rd UP Forecast | 93.83 |
| 2nd UP Forecast | 90.91 |
| 1st UP Forecast | 87.99 |
| 1st DOWN Forecast | 79.65 |
| 2nd DOWN Forecast | 76.73 |
| 3rd DOWN Forecast | 73.81 |
| 4th DOWN Forecast | 69.08 |
EKTA-B Forecast2024
| 4th UP Forecast | 207.55 |
| 3rd UP Forecast | 167.87 |
| 2nd UP Forecast | 143.34 |
| 1st UP Forecast | 118.81 |
| 1st DOWN Forecast | 48.83 |
| 2nd DOWN Forecast | 24.3 |
| 3rd DOWN Forecast | -0.23 |
| 4th DOWN Forecast | -39.91 |
Elekta AB (publ) ( ST Sweden Symbol : EKTA-B )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EKTA-B Business Profile
Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems. In addition, the company offers radiosurgery systems under the Leksell Gamma Knife Icon, Leksell Gamma Knife Perfexion, and Elekta Axesse names; Leksell GammaPlan, a treatment planning software; and Elekta Unity, a magnetic resonance radiation therapy solution. Further, it provides care management software, such as MOSAIQ Radiation Oncology and MOSAIQ Medical Oncology; MOSAIQ IQ Scripts, a workflow automation and customization tool; Patient Engagement, a patient communication tool; MOSAIQ Evaluate, a plan management and dose review solution; MOSAIQ Locate, a stereotactic localization solution; and METRIQ, a cancer registry data management solution. Additionally, the company offers Flexitron, a remote after loading platform; Esteya, an electronic brachytherapy for treating skin cancer; Oncentra Brachy, a treatment planning software; real-time prostate solutions; and gynecological brachytherapy, bronchus and esophagus, breast, prostate, rectum and bladder, and skin applicators, as well as brachytherapy needles and flexible implant tubes. It also provides Leksell Vantage Stereotactic System for neuroimaging and treatment; Leksell Stereotactic System for minimally invasive stereotactic neurosurgery; and proton therapy components. The company was founded in 1972 and is headquartered in Stockholm, Sweden. Address: Kungstensgatan 18, Stockholm, Sweden, 103 93
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service